This page offers clinical and educational resources for healthcare providers to enhance clinical practice and empower patients to play a major role in their healthcare. We encourage members of all healthcare sectors to explore these resources and take advantage of any and all opportunities to improve your organization/health center/practice.
Assessing Benefits Harms of Opioid Therapy.pdf
PATIENT EDUCATION MATERIALS
The MAT Advisory Group is a peer support and resource group of physicians, advanced practice clinicians, and behavioral health providers focused on improving opioid use disorder recovery capacity and quality in Santa Cruz and Monterey Counties.
The Advisory Group convenes periodic in-person gatherings in addition to other forms of support: local mentors willing to guide providers that already have or are interested in obtaining a buprenorphine waiver; a Google Group for case discussions, questions, and answers; as well as a Google Drive folder with training and prescribing resources.
We invite all interested healthcare providers to join the MAT Advisory Group.
OPIOID SAFETY EDUCATIONAL
California Bridge Statewide Training Series
About: The California Bridge Program will conduct a series of day-long statewide training sessions to provide in-depth education and motivation that is necessary to push forward hospital programs to offer 24/7 access to treatment for patients with substance use disorders.
The first training session on February 25th will be open to all hospital providers in California. Subsequent trainings may be limited to specific program participants.
- Learn specific solutions to provide and refine access to MOUD at your hospital
- Review the fundamental details of medications for opioid use disorder
- Shape the culture and language around opioid use disorder and the pathways to treatment
- Grow your network of MOUD providers at your hospital and in your region
Training Session #3: November 15, 2019
– (Registration for Training Session #3 will open ASAP)
Training Session #4: April 2020
– (Registration for Training Session #4 will open on November 15th)
Providers Clinical Support System MAT Overview and Waiver Training
About: While PCSS provides trainings on a broad range of substance use disorder treatments, its primary focus is on treatment of opioid use disorders (OUD). Opioids include a class of drugs often prescribed for pain—morphine, fentanyl, oxycodone, and hydrocodone—as well as illicit drugs, such as heroin. The Federal Drug Administration (FDA) has approved three medications for the treatment of OUD: methadone, buprenorphine, and naltrexone.
The introductory module below is a case-based discussion of the general approach to evaluation and treatment of patients presenting with problematic opioid use. Benefits and limitations of available medications and differences between them are described. An approach to choosing first and second line treatments is also presented.
Learn about MAT Waiver Training for:
American Academy of Addiction Psychiatry (AAAP) 8 Hour Online MAT Waiver Training
About: The American Academy of Addiction Psychiatry (AAAP) is accredited by the ACCME to provide continuing medical education for physicians. American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of participation in the activity:
To be awarded a maximum of 8 AMA PRA Category 1 Credits™ and a MAT Waiver Training Certificate you must:
Review 8 training modules (8 hours) provided in this activity.
Earn a minimum cumulative score of 75% on the examination. Participants will have three opportunities to correctly answer the examination.
Complete a final evaluation and follow instructions at the end of the course regarding how to retrieve your Certificate of Completion as well as a CME Credit Certificate*.
*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.
At the conclusion of this activity, learners should be able to:
Review addiction identification and evidence-based treatments.
Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
Explain the process of buprenorphine induction as well as stabilization and maintenance.
Discuss other approved antagonist and agonist medications to treat OUD.
Discuss basic office protocols including medical record documentation and confidentially.
Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
Apply for a MAT Waiver Training Certificate to begin treating patients with OUD.
The ASAM Fundamentals of Addiction Medicine 40-Hour CME Program
The ASAM Fundamentals of Addiction Medicine 40-Hour CME Program is an innovative educational program empowering primary care and other providers to diagnose and treat patients at risk for or with addiction.
Over 40 CME hours of on-demand 24/7, interactive, case-based learning which addresses how to recognize, screen, treat and refer patients with addiction
Translates the science of addiction medicine into transformative, positive outcomes for patients
A program that provides the fundamental knowledge of addiction and allows participants to select topics based on interests and the needs of patients
Designed for busy providers with content available in a variety of formats including online, on-demand 24/7, live, live video
The ASAM Fundamentals of Addiction Medicine 40-Hour Program is comprised of five activities (defined below) that together equal a total of 40 CME hours. Click on the links below to learn more about each component of the program.